Last reviewed · How we verify

NCT04438967

Brain Health in the Time of COVID-19

Status unknown Last updated 6 January 2021
What this trial tests

trial in Brain Health in 10,000 participants. Status unknown.

Timeline
16 June 2020
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorMiro Health
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment10,000
Start date16 June 2020
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across United States

Conditions studied

Sponsor

Miro Health

Who can join

18 and older, any sex, with Brain Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a nationwide research program to study the neurological effects of COVID-19. It is open to the public. Healthy individuals and individuals who are or have been infected with COVID-19 are encouraged to join the effort. The study can be done at home with internet access and an iPad or iPhone. Participation takes about one hour. To learn more, go to https://www.mirohealth.com/consent/

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Brain Health

Currently open trials in the same condition.

Other Miro Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04438967.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing